A MEDICAL EDUCATION COMMUNITY FOR HEMATOLOGISTS AND ONCOLOGISTS

FEATURED WEBINAR

Breakthrough Therapies for Acute Graft-Versus-Host-Disease

Release Date: May 16, 2018
Expiration Date: May 16, 2019

Optimal Use of Autologous Transplantation and Stem Cell Mobilization in Patients with Multiple Myeloma and Non-Hodgkin’s Lymphoma

Accredited for 1 CME Credit
The goal of this educational program is to improve the treatment of patients with multiple myeloma (MM) and non-hodgkin lymphoma (NHL) through the dissemination of information about stem cell transplantation and mobilization for autologous hematopoietic cell transplantation. The data for stem cell transplantation in MM is rapidly changing. The techniques of mobilization are still evolving. There is considerable debate regarding the timing and number of transplants for MM and the indications for transplant in NHL. The optimal use of transplant in the disease course and appropriate mobilization could drastically change the treatment of MM and NHL.

PREVIOUS WEBINARS

FEATURED BMT REVIEWS

IMAGE ATLAS

Explore Our Directory of Blood Slides